ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RNXT vs OSTX // PIOTROSKI F-SCORE QUALITY

RenovoRx Inc. (NASDAQ) VS. OS Therapies Incorporated (NYSE) • 15-METRIC TALLY: RNXT 3 — OSTX 1
▲ PIOTROSKI F-SCORE QUALITY LEADER: RNXT
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RNXT VS. OSTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RNXT OSTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 70.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -16.32% -21.07% +4.75 RNXT /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.40 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 4/9 1/9 +3.00 RNXT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.1 33.8 +13.28 RNXT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $67.2M $67.6M -$341.5K OSTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RNXT REV OSTX REV RNXT GROSS % OSTX GROSS % RNXT FCF OSTX FCF
FY 2025 $1.1M $0 70.9% — -$11.0M -$14.2M
FY 2024 $43.0K $0 98.0% — -$9.1M -$7.3M
FY 2023 $0 $0 — — -$10.3M -$3.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RNXT // BETA —
OSTX // BETA —